


Healthcare Industry NewsFeed
HSMN NewsFeed - 20 Dec 2013
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
HSMN NewsFeed - 20 Dec 2013
Baxter Completes CE Mark Approval for VIVIA Hemodialysis System in Europe
Baxter Completes CE Mark Approval for VIVIA Hemodialysis System in Europe
HSMN NewsFeed - 19 Dec 2013
ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
HSMN NewsFeed - 19 Dec 2013
Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors
Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors
HSMN NewsFeed - 19 Dec 2013
Nexstim’s Navigated Brain Stimulation Shown to Improve Patient Outcomes in Challenging Brain Surgery
Nexstim’s Navigated Brain Stimulation Shown to Improve Patient Outcomes in Challenging Brain Surgery
HSMN NewsFeed - 19 Dec 2013
Genzyme’s Lemtrada(TM) Approved in Australia for Treatment of Multiple Sclerosis
Genzyme’s Lemtrada(TM) Approved in Australia for Treatment of Multiple Sclerosis
HSMN NewsFeed - 19 Dec 2013
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
HSMN NewsFeed - 19 Dec 2013
Cutera Appoints Scott Ashworth as Executive Vice President of Global Sales
Cutera Appoints Scott Ashworth as Executive Vice President of Global Sales
HSMN NewsFeed - 19 Dec 2013
Mazor Robotics Receives First Purchase Order for Renaissance(TM) System from Turkey Distribution Partner
Mazor Robotics Receives First Purchase Order for Renaissance(TM) System from Turkey Distribution Partner
HSMN NewsFeed - 19 Dec 2013
Bristol-Myers Squibb Continues Evolution to Specialty BioPharma Through Sale of Its Diabetes Business
Bristol-Myers Squibb Continues Evolution to Specialty BioPharma Through Sale of Its Diabetes Business
HSMN NewsFeed - 18 Dec 2013
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
HSMN NewsFeed - 18 Dec 2013
Elekta announces strategic partnership with McLaren Health Care to improve cancer care in Michigan
Elekta announces strategic partnership with McLaren Health Care to improve cancer care in Michigan
HSMN NewsFeed - 17 Dec 2013
Pfizer Names Albert Bourla Group President, Vaccines, Oncology and Consumer Healthcare Business
Pfizer Names Albert Bourla Group President, Vaccines, Oncology and Consumer Healthcare Business
HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
HSMN NewsFeed - 17 Dec 2013
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
HSMN NewsFeed - 17 Dec 2013
ViewRay(TM) Closes a $30M Financing to Expedite Commercialization of its MRI-Guided Radiation Therapy System
ViewRay(TM) Closes a $30M Financing to Expedite Commercialization of its MRI-Guided Radiation Therapy System
HSMN NewsFeed - 17 Dec 2013
Provectus Announces Name Change to Provectus Biopharmaceuticals, Inc. and Reincorporates in Delaware
Provectus Announces Name Change to Provectus Biopharmaceuticals, Inc. and Reincorporates in Delaware
HSMN NewsFeed - 17 Dec 2013
Baptist Medical Center Jacksonville (FL) Acquires a Second Renaissance System from Mazor Robotics
Baptist Medical Center Jacksonville (FL) Acquires a Second Renaissance System from Mazor Robotics
HSMN NewsFeed - 16 Dec 2013
Neurotrope, Inc., Appoints James Gottlieb to the Company's Board of Directors
Neurotrope, Inc., Appoints James Gottlieb to the Company's Board of Directors
HSMN NewsFeed - 16 Dec 2013
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
HSMN NewsFeed - 16 Dec 2013
Everett Laboratories Acquires Quinnova Pharmaceuticals to Diversify U.S. Pharmaceutical Presence
Everett Laboratories Acquires Quinnova Pharmaceuticals to Diversify U.S. Pharmaceutical Presence
HSMN NewsFeed - 16 Dec 2013
Premier Biomedical Secures $5 Million Equity Funding From Kodiak Capital Group, LLC
Premier Biomedical Secures $5 Million Equity Funding From Kodiak Capital Group, LLC
HSMN NewsFeed - 16 Dec 2013
AcelRx and Grunenthal Announce Collaboration for EU Commercialization of ZALVISO(TM)
AcelRx and Grunenthal Announce Collaboration for EU Commercialization of ZALVISO(TM)
HSMN NewsFeed - 16 Dec 2013
Bovie Medical Corporation Closes Strategic $7.0M Equity Investment Through Great Point Partners
Bovie Medical Corporation Closes Strategic $7.0M Equity Investment Through Great Point Partners
HSMN NewsFeed - 13 Dec 2013
The Orthopaedic Implant Company Releases High Value Proximal Humerus Plate
The Orthopaedic Implant Company Releases High Value Proximal Humerus Plate
HSMN NewsFeed - 13 Dec 2013
Nucletron, an Elekta company, Installs Esteya for Treating Skin Cancer in Major US Center
Nucletron, an Elekta company, Installs Esteya for Treating Skin Cancer in Major US Center
HSMN NewsFeed - 13 Dec 2013
Genzyme’s Lemtrada(TM) Approved in Canada for Treatment of Multiple Sclerosis
Genzyme’s Lemtrada(TM) Approved in Canada for Treatment of Multiple Sclerosis
HSMN NewsFeed - 12 Dec 2013
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
HSMN NewsFeed - 12 Dec 2013
St. Jude Medical Gains CE Mark for 25 mm Portico Transcatheter Aortic Heart Valve
St. Jude Medical Gains CE Mark for 25 mm Portico Transcatheter Aortic Heart Valve
HSMN NewsFeed - 12 Dec 2013
Momenta Pharmaceuticals Appoints Michael Franken, M.D. as President, Biosimilars Business
Momenta Pharmaceuticals Appoints Michael Franken, M.D. as President, Biosimilars Business
HSMN NewsFeed - 11 Dec 2013
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
HSMN NewsFeed - 11 Dec 2013
The Female Health Company Names Karen King President and Chief Executive Officer
The Female Health Company Names Karen King President and Chief Executive Officer
HSMN NewsFeed - 11 Dec 2013
Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer
Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer
HSMN NewsFeed - 10 Dec 2013
Medtronic Announces First Human Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker
Medtronic Announces First Human Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker
HSMN NewsFeed - 10 Dec 2013
AngioDynamics Comments on New Reimbursement Rate for Hospital-Based Varicose Vein Ablations
AngioDynamics Comments on New Reimbursement Rate for Hospital-Based Varicose Vein Ablations
HSMN NewsFeed - 9 Dec 2013
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
HSMN NewsFeed - 9 Dec 2013
New Era Orthopaedics Announces Exclusive Distribution Agreement with NeoSteo
New Era Orthopaedics Announces Exclusive Distribution Agreement with NeoSteo
HSMN NewsFeed - 9 Dec 2013
Kamada Announces Appointment of Amir London as Senior Vice President, Business Development
Kamada Announces Appointment of Amir London as Senior Vice President, Business Development
HSMN NewsFeed - 9 Dec 2013
LabCorp to Offer the IntelliGENTM Multi-Gene Oncology Panel on the Next Generation Sequencing Platform
LabCorp to Offer the IntelliGENTM Multi-Gene Oncology Panel on the Next Generation Sequencing Platform
HSMN NewsFeed - 9 Dec 2013
Hologic Appoints Stephen P. MacMillan President and Chief Executive Officer
Hologic Appoints Stephen P. MacMillan President and Chief Executive Officer
